Form 4 · Filed May 29, 2026, 12:15 AM UTC
RNTX/Rein Therapeutics, Inc.
VON RICKENBACH JOSEF H — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 27, 2026 | P | buy | 4,500 | $1 | $4,819 | 62,514 |
| May 26, 2026 | P | buy | 23,190 | $1 | $24,470 | 58,014 |
| May 22, 2026 | P | buy | 15,950 | $1 | $16,708 | 34,824 |
| May 21, 2026 | P | buy | 3,420 | $1 | $3,564 | 18,874 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-245832